During the past decade, Desert Regional Medical Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 17 clinical trials were completed, i.e. on average, 56.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Desert Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Desert Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Desert Regional Medical Center" are "Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Desert Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Desert Regional Medical Center" are "Drug" (41 trials), "Other" (31 trials), "Biological" (20 trials), "Radiation" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (9 trials), "Biospecimen Collection" (7 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Desert Regional Medical Center" are 45 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Desert Regional Medical Center". undefined are not yet recruiting, 15 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Desert Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Desert Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".